D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
General Mills
GIS
$19.2B
| $6.67M | 0.01% |
105,228
-32,956
| -24% | -$1.92M |
|
1077
TherapeuticsMD
TXMD
$23.8M
| $6.66M | 0.01% |
20,799
+4,068
| +24% | +$1.39M |
|
|
SVC
1078
Service Properties Trust
SVC
$1.1B
| $6.65M | 0.01% |
+50,047
| New | +$6.07M |
|
1079
PUT
F5
FFIV
$22.1B
| $6.64M | 0.01% |
62,700
-7,700
| -11% | -$738K |
|
1080
CALL
Equinix
EQIX
$107B
| $6.61M | 0.01% |
20,000
-31,500
| -61% | -$9.58M |
|
1081
PUT
Under Armour
UAA
$3B
| $6.6M | 0.01% |
156,704
-484,213
| -76% | -$19M |
|
|
CMA.WS
1082
DELISTED
Comerica Incorporated Ws
CMA.WS
| $6.55M | 0.01% |
500,000
| – | – |
|
1083
Silicon Laboratories
SLAB
$7.15B
| $6.54M | 0.01% |
145,544
-21,726
| -13% | -$935K |
|
1084
CALL
GoPro
GPRO
$116M
| $6.53M | 0.01% |
546,200
-69,100
| -11% | -$857K |
|
1085
Kulicke & Soffa
KLIC
$5.3B
| $6.53M | 0.01% |
577,069
+412,928
| +252% | +$4.5M |
|
|
AHL
1086
DELISTED
ASPEN Insurance Holding Limited
AHL
| $6.53M | 0.01% |
136,817
-45,637
| -25% | -$2.08M |
|
1087
Huntington Bancshares
HBAN
$35.1B
| $6.52M | 0.01% |
+683,762
| New | +$6.31M |
|
|
RTN
1088
CALL
DELISTED
Raytheon Company
RTN
| $6.52M | 0.01% |
53,200
-113,200
| -68% | -$13.9M |
|
1089
PUT
Expedia Group
EXPE
$31.2B
| $6.5M | 0.01% |
60,300
-75,020
| -55% | -$8M |
|
1090
Western Alliance Bancorporation
WAL
$9.07B
| $6.49M | 0.01% |
194,512
+1,669
| +0.9% | +$52.2K |
|
1091
Entravision Communication
EVC
$983M
| $6.48M | 0.01% |
871,569
+105,736
| +14% | +$780K |
|
1092
Coca-Cola Europacific Partners
CCEP
$46.5B
| $6.47M | 0.01% |
127,524
-1,631,899
| -93% | -$78.6M |
|
1093
Microchip Technology
MCHP
$42.8B
| $6.46M | 0.01% |
268,214
-270,776
| -50% | -$6.03M |
|
1094
CALL
Pfizer
PFE
$140B
| $6.45M | 0.01% |
229,245
-1,008,256
| -81% | -$28.8M |
|
|
BLD
1095
DELISTED
TopBuild
BLD
| $6.44M | 0.01% |
216,591
-280,113
| -56% | -$7.57M |
|
1096
PUT
Polaris
PII
$4.15B
| $6.44M | 0.01% |
65,400
+11,400
| +21% | +$989K |
|
1097
CALL
Tyson Foods
TSN
$20.2B
| $6.41M | 0.01% |
96,200
+21,800
| +29% | +$1.31M |
|
1098
Healthpeak Properties
DOC
$15.4B
| $6.39M | 0.01% |
+215,411
| New | +$6.46M |
|
1099
PUT
Eastman Chemical
EMN
$7.8B
| $6.39M | 0.01% |
88,500
-39,500
| -31% | -$2.59M |
|
1100
HCA Healthcare
HCA
$84.8B
| $6.38M | 0.01% |
81,745
-1,614,852
| -95% | -$113M |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.